Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy

Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy

Introduction Current treatment regimens for multidrug-resistant tuberculosis (MDR-TB) are long, poorly tolerated and have poor outcomes. Furthermore, the costs of treating MDR-TB are much greater than those for treating drug-susceptible TB, both for health service and patient-incurred costs. Urgent...

Full description

Bibliographic Details
Main Authors: Sedona Sweeney, Nichola Kitson, Animesh Sinha, Natalia Yatskevich, Suzanne Staples, Ronelle Moodliar, Sharon Motlhako, Matshepo Maloma, Mohammed Rassool, Nosipho Ngubane, Ella Ndlovu, Bern-Thomas Nyang'wa
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/10/e036599.full

Internet

https://bmjopen.bmj.com/content/10/10/e036599.full

Similar Items